US68218J1034 - Common Stock
OMNIAB INC
NASDAQ:OABI (11/12/2024, 8:22:16 PM)
After market: 4.15 -0.34 (-7.57%)4.49
-0.11 (-2.39%)
OmniAb, Inc. operates as a drug discovery company. The company is headquartered in Emeryville, California and currently employs 106 full-time employees. The company went IPO on 2020-10-09. The OmniAb platform is the biological intelligence (BI) of transgenic animals, including OmniRat, OmniChicken, and OmniMouse, which have been genetically modified to generate antibodies with human sequences to facilitate the development of human therapeutic candidates. The Company’s OmniFlic (transgenic rat) and OmniClic (transgenic chicken) address industry needs for bispecific antibody applications through a common light chain approach, and OmniTaur features structural attributes of cow antibodies for complex targets. The firm's OmniChicken and OmniClic offer affinity-matured antibodies in an evolutionarily distant chicken host environment, which can deliver a diverse repertoire of antibody panels to conserved therapeutic target antigens.
OMNIAB INC
5980 Horton Street, Suite 600
Emeryville CALIFORNIA
P: 15102507800
Employees: 106
Website: https://www.omniab.com/
Get insights into the top gainers and losers of Tuesday's after-hours session.
Here you can normally see the latest stock twits on OABI, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: